[PDF] Top 20 Producción de avellanas en el Valle Inferior del Río Negro

... for breast cancer prognosis due to its complexity and the lack of standardization among models and ...molecular indicators that help individualized therapeutic ...a prognostic indicator ... See full document

... proven prognostic in metastatic dis- ease [2, 9] we could not demonstrate any lead-time effect, in that none of the QL indicators, (apart from the possibly chance finding of mood at 2 months), measured at ... See full document

... known prognostic genes, such as ER and HER2; therefore, the identification of useful prognostic indicators among the VEGF family members could have potential applications in similar multigene ... See full document

... decrease postoperatively strongly indicates the signifi- cance of baseline rather than postoperative levels as prognostic indicators. Although CEA and CA15-3 were significantly associated with tumor size, ... See full document

... significant breast cancer mortality because of very few treatment ...as prognostic or predictive indicators as well as suggest possible targets for novel ...the breast cancer, so ... See full document

... Background: Breast cancer is the commonest female malignancy globally and the second (after uterine cervix) in sub-Saharan Africa including ...Tanzania. Prognostic indicators reportedly ... See full document

... study, breast cancer is classified into five groups as follows: luminal A (ER-and/or PR-positive/HER2-negative /low Ki-67), luminal B (ER- and/or PR-positive/HER2-negative/high Ki-67), HER2-positive luminal ... See full document

... negative breast cancer (TNBC) is de fi ned by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), which occupies 12 – 17% of newly diagnosed ... See full document

... available prognostic mar- kers do not adequately stratify breast cancer - this is backed up by data from the Oxford overviews [1], which show that a significant minority of patients do not require ... See full document

... primary breast cancer samples of stage I to III invasive ductal carcinoma cases were collected randomly at the Department of Breast Surgery in Fudan University Shanghai Cancer Center (FDUSCC, ... See full document

... There are ongoing randomized clinical trials compar- ing SLN biopsy to no axillary surgery in patients with cT1–2N0M0 breast cancer, in which cN0 is evaluated by AUS and/or ultrasonography-guided biopsy [4, ... See full document

... triple-negative breast cancer patients who received neoadjuvant chemother- apy at The Third Affiliated Hospital of Soochow University from October 2006 to December 2015 were ... See full document

... Results: The medial age was 51 years old. The medial tumor size was 35.4 mm. Clinically, 67.2% of the patients were staged cT2 and 63.2%, cN1i. Breast conservation was achieved in 41% of cases. In the histologic ... See full document

... Early Breast Cancer 2013 distinguished lu- minal A-like breast cancer from luminal B-like disease based on immunohistochemical stains of ER, PR, and Ki-67 status without a requirement for ... See full document

... inflammatory indicators have intrinsic correlations, only the CRP/Alb ratio – which had the high- est theoretical discriminatory ability detected by the ROC analysis – was involved in the multivariate analysis, ... See full document

... Many women in older age are deprived of this tool, mainly for three reasons: 1) Comorbidities affecting the possibility of adjuvant therapy; 2) a poor life expectancy; 3) avoidance of morbidity related to axillary ... See full document

... of breast cancer, we aim to obtain a ranked list of drugs which would make suitable candidates for drug repurposing and drug repositioning for all ten breast cancer ... See full document

... differentiate cancer from malignant cases, (2) Both clustering methods: hierarchical clustering and SOM, selected the age, shape, margin, DW ratio, blood level and CRD features for classification with about 81% ... See full document

... reported alternative for identification of ‘functional’ loss of wild-type p53 is a p53 transcriptional fingerprint. Sev- eral gene expression signatures have been reported that distinguish between wild-type and mutant ... See full document

... Materials and methods: Preoperative blood samples for serum CA 15.3 levels were taken in 112 breast cancer patients who underwent breast-conserving surgery or modified radical mastectomy between ... See full document